Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Rituximab × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 77 Lymphoma 48 Lymphoma, Non-Hodgkin 47 Lymphoma, Mantle-Cell 47 Lymphoma, Follicular 47 Lymphoma, B-Cell, Marginal Zone 41 Leukemia, Lymphocytic, Chronic, B-Cell 40 Lymphoma, B-Cell 28 Burkitt Lymphoma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Waldenstrom Macroglobulinemia 17 Recurrence 17 Neoplasms 12 Leukemia 12 Leukemia, Hairy Cell 8 Hodgkin Disease 8 Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm, Residual 4 Lymphoproliferative Disorders 4 Hematologic Diseases 4 Dendritic Cell Sarcoma, Interdigitating 4 Lymphoma, AIDS-Related 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Biphenotypic, Acute 3 Blast Crisis 3

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡